SeqLL (NASDAQ:SQL – Get Rating) and Avantor (NYSE:AVTR – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.
Earnings and Valuation
This table compares SeqLL and Avantor’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeqLL | $210,000.00 | 45.85 | -$3.70 million | N/A | N/A |
| Avantor | $7.39 billion | 2.61 | $572.60 million | $0.89 | 35.52 |
Avantor has higher revenue and earnings than SeqLL.
Profitability
This table compares SeqLL and Avantor’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeqLL | N/A | N/A | N/A |
| Avantor | 7.72% | 32.17% | 7.31% |
Analyst Ratings
This is a breakdown of current ratings and target prices for SeqLL and Avantor, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeqLL | 0 | 0 | 1 | 0 | 3.00 |
| Avantor | 0 | 1 | 15 | 0 | 2.94 |
SeqLL currently has a consensus target price of $3.00, indicating a potential upside of 270.37%. Avantor has a consensus target price of $43.60, indicating a potential upside of 37.93%. Given SeqLL’s stronger consensus rating and higher probable upside, equities research analysts clearly believe SeqLL is more favorable than Avantor.
Institutional and Insider Ownership
2.1% of SeqLL shares are owned by institutional investors. Comparatively, 93.2% of Avantor shares are owned by institutional investors. 1.6% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Avantor beats SeqLL on 8 of the 11 factors compared between the two stocks.
About SeqLL (Get Rating)
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
About Avantor (Get Rating)
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Receive News & Ratings for SeqLL Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for SeqLL and related companies with MarketBeat.com’s FREE daily email newsletter.
